GlucoTrack Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized as of March 28, 2024.
| GLUCOTRACK, INC. | |
| By: | /s/ Paul Goode |
| Name: | Paul Goode |
| Title: | Chief Executive Officer (Principal Executive Officer) |
| By: | /s/ James Cardwell |
| Name: | James Cardwell |
| Title: | Chief Financial Officer (Principal Financial Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ James Cardwell | Chief Financial Officer | March 28, 2024 |
| James Cardwell | (Principal Executive and Financial Officer and Principal Accounting Officer) | |
| /s/ Robert Fischell | Director | March 28, 2024 |
| Dr. Robert Fischell | ||
| /s/ Shimon Rapps | Director | March 28, 2024 |
| Shimon Rapps | ||
| /s/ Paul V. Goode | CEO | March 28, 2024 |
| Paul V. Goode | ||
| /s/ Luis Malave | Director | March 28, 2024 |
| Luis Malave | ||
as of December 31, 2023
Table of Contents
| Page | |
| Report of Independent Registered Public Accounting Firm – PCAOB ID NUMBER 1375 | F-2 |
|---|---|
| Consolidated Financial Statements | |
| Balance Sheets | F-4 |
| Statements of Operations and Comprehensive Loss | F-5 |
| Statements of Changes in Stockholders’ Equity | F-6 |
| Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 – F-26 |
Fahn Kanne & Co.
Head Office
32 Hamasger Street
Tel-Aviv 6721118, ISRAEL
PO Box 36172, 6136101
T +972 3 7106666
F +972 3 7106660
www.gtfk.co.il
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.